INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,437 | -17.8% | 7,745 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $490,920 | +136.0% | 7,753 | +101.8% | 0.00% | – |
| Q1 2023 | $208,044 | +3.5% | 3,842 | +1.1% | 0.00% | – |
| Q4 2022 | $201,096 | +14.3% | 3,800 | 0.0% | 0.00% | – |
| Q3 2022 | $176,000 | -97.2% | 3,800 | -96.5% | 0.00% | -100.0% |
| Q2 2022 | $6,213,000 | -77.1% | 108,873 | -75.5% | 0.01% | -72.3% |
| Q1 2022 | $27,187,000 | +35.8% | 444,375 | +16.1% | 0.05% | +46.9% |
| Q4 2021 | $20,025,000 | +34.8% | 382,619 | -4.0% | 0.03% | +28.0% |
| Q3 2021 | $14,854,000 | +33.7% | 398,489 | +46.3% | 0.02% | +31.6% |
| Q2 2021 | $11,114,000 | +3340.9% | 272,321 | +2756.3% | 0.02% | +1800.0% |
| Q1 2021 | $323,000 | +74.6% | 9,534 | +31.6% | 0.00% | – |
| Q3 2020 | $185,000 | 0.0% | 7,245 | 0.0% | 0.00% | – |
| Q2 2020 | $185,000 | -90.7% | 7,245 | -87.5% | 0.00% | -100.0% |
| Q4 2019 | $1,987,000 | +731.4% | 57,972 | +81.2% | 0.00% | – |
| Q3 2019 | $239,000 | +3.9% | 32,001 | +80.8% | 0.00% | – |
| Q2 2019 | $230,000 | +70.4% | 17,700 | +59.5% | 0.00% | – |
| Q1 2019 | $135,000 | +187.2% | 11,100 | +170.7% | 0.00% | – |
| Q4 2018 | $47,000 | -50.0% | 4,100 | -33.9% | 0.00% | – |
| Q4 2017 | $94,000 | -6.9% | 6,200 | -3.1% | 0.00% | – |
| Q3 2017 | $101,000 | -83.8% | 6,400 | -83.3% | 0.00% | -100.0% |
| Q1 2017 | $623,000 | +8.5% | 38,357 | +3.8% | 0.00% | 0.0% |
| Q4 2016 | $574,000 | – | 36,955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |